Drug Discovery

Deal designed to strengthen Zoetis' core livestock business, and boost its presence in the fast-growing segment of aquatic health products serving aquaculture

Facility will add 100 million doses to firm’s current 50 million dose capacity. FDA approved Sanofi Pasteur’s new manufacturing facility for the production of seasonal...

Access to both firms' services will be given through a single contract. Radiant Research will forge a partnership with Spectrum Clinical Research to provide CRO...

Scientists in Korea using a 3-D printed drug microcarrier have shown in animal models that the carrier maintained robust integrity and delivered a local, sustained load of cyclosporine A (CsA) in an amount that overcame the need for additional drugs to treat immune rejection.

Allergan said it will develop new small molecule drugs with Rugen, whose compounds for autism and obsessive compulsive disorder have shown efficacy in animal models

$4M-plus acquisition designed to speed up its checkpoint inhibitor collaborations with Merck & Co. and Incyte.

A group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the virus that causes AIDS.

Novartis will pay Conatus $7M option fee, co-fund existing Phase IIb studies, and fund all Phase III emricasan monotherapy and combination therapy trials

Indian firm will use label-free detection platform for in-house and contract discovery.

Amgen has pulled the plug on its IGF1R monoclonal antibody candidate ganitumab, after an interim analysis of an ongoing Phase III study failed to show any benefits of combining the drug with gemcitabine therapy in patients with metastatic pancreatic cancer.